Stephan Schwers

Receptor Editing in a Transgenic Mouse Model: Site, Efficiency, and Role in B Cell Tolerance and Antibody Diversification

Roberta Pelanda, Stephan Schwers, Eiichiro Sonoda et al. · Immunity · 1997 · 290 citations · Full text

Knockout Mouse, Immunogenetics, Transgenic Mouse Models +8

B Cell Development under the Condition of Allelic Inclusion

Eiichiro Sonoda, Yael Pewzner‐Jung, Stephan Schwers et al. · Immunity · 1997 · 245 citations · Full text

Cell Lineage, Developmental Biology, Lymphocyte Development +7

Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring

Wolfgang Mueck, Stephan Schwers, Jan Stampfuss · Thrombosis Journal · 2013 · 164 citations · Full text

First evaluation of the safety, pharmacokinetics, and pharmacodynamics of BAY 2433334, a small molecule targeting coagulation factor XIa

Dirk Thomas, Friederike Kanefendt, Stephan Schwers et al. · Journal of Thrombosis and Haemostasis · 2021 · 79 citations · Full text

BAY 1213790, a fully human IgG1 antibody targeting coagulation factor XIa: First evaluation of safety, pharmacodynamics, and pharmacokinetics

Dirk Thomas, Kirstin Thelen, Stefanie Kraff et al. · Research and Practice in Thrombosis and Haemostasis · 2019 · 76 citations · Full text